AU Patent

AU2009243408B2 — Controlled release preparation

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2012-01-19 · 14y expired

What this patent protects

A controlled release preparation wherein the release of active ingredient is controlled, which releases an active ingredient for an extended period of time by 5 staying or slowly migrating in the gastrointestinal tract, is provided by means such as capsulating a tablet, granule o…

USPTO Abstract

A controlled release preparation wherein the release of active ingredient is controlled, which releases an active ingredient for an extended period of time by 5 staying or slowly migrating in the gastrointestinal tract, is provided by means such as capsulating a tablet, granule or fine granule wherein the release of active ingredient is controlled and a gel-forming polymer. Said tablet, granule or fine granule has a 10 release-controlled coating-layer formed on a core particle containing an active ingredient. 21291001 (GHMatters) 25/11/09

Drugs covered by this patent

Patent Metadata

Patent number
AU2009243408B2
Jurisdiction
AU
Classification
—
Expires
2012-01-19
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.